# Therapeutic potential of pycnogenol: antioxidant, anti-inflammatory, immunomodulatory, antiviral, and anticancer effects

**Authors:** Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama-Kohara

PMC · DOI: 10.3389/fphar.2026.1755175 · Frontiers in Pharmacology · 2026-03-09

## TL;DR

Pycnogenol, a pine bark extract, shows potential as a treatment for various conditions due to its antioxidant, anti-inflammatory, and anticancer properties.

## Contribution

This review compiles evidence of Pycnogenol's broad biological effects and highlights its potential for antiviral and anticancer drug development.

## Key findings

- Pycnogenol exhibits antioxidant, anti-inflammatory, and antiviral effects against viruses like hepatitis C and SARS-CoV-2.
- It modulates cell signaling pathways to inhibit tumor growth and induce apoptosis.
- Further clinical validation is needed to confirm its therapeutic applications.

## Abstract

Pycnogenol (PYC), a standardized extract derived from the bark of the French maritime pine (Pinus pinaster ssp. atlantica), exhibits a broad spectrum of biological activities, including antioxidant, anti-inflammatory, immunomodulatory, antiviral, and anticancer effects. These effects are attributed to the rich profile of polyphenolic compounds, which confer potent antioxidant and anti-inflammatory properties. Viral infections frequently induce oxidative stress, inflammation, and immune dysregulation, thereby posing substantial challenges to global public health. Accordingly, the development of effective antiviral agents applicable across diverse viral outbreak settings remains a critical goal. PYC has demonstrated antioxidant, anti-inflammatory, and antiviral potential against several viruses, including hepatitis C virus, dengue virus, and severe acute respiratory syndrome coronavirus 2. In addition, PYC exhibited anticancer activity by modulating cell signaling pathways, inhibiting tumor cell proliferation, inducing apoptosis, and suppressing angiogenesis. However, further research and clinical validation are required to confirm its therapeutic applications. Accordingly, this review summarizes the current understanding regarding the antioxidant, anti-inflammatory, and anticancer mechanisms of PYC. Moreover, the review highlights its immunomodulatory properties to inform future antiviral and anticancer drug development and therapeutic strategies.

## Linked entities

- **Diseases:** severe acute respiratory syndrome coronavirus 2 (MONDO:0100096)

## Full-text entities

- **Diseases:** Viral infections (MESH:D014777), tumor (MESH:D009369), immune dysregulation (OMIM:614878), inflammation (MESH:D007249)
- **Chemicals:** polyphenolic compounds (-), PYC (MESH:C024070)
- **Species:** Dengue virus (no rank) [taxon 12637], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], hepatitis C virus [taxon 11103], Pinus pinaster (cluster pine, species) [taxon 71647]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13006791/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13006791/full.md

## References

105 references — full list in the complete paper: https://tomesphere.com/paper/PMC13006791/full.md

---
Source: https://tomesphere.com/paper/PMC13006791